Ultrasonic interventional analgesia in pancreatic carcinoma with chemical destruction of celiac ganglion

Table 3 Blood T cell subtypes (%) and β-EP (nmol/L) pre- and post-operation (mean ± SD)

Index	Control(n = 38)	Therapeutic (n = 96)
		Pre-	Postoperation
			3 d	7 d	15 d	30 d
CD3+	70.3 ± 4.9	46.7 ± 3.7	48.8 ± 5.1	58.7 ± 3.7b	62.5 ± 5.5b	61.2 ± 6.1b
CD4+	46.6 ± 5.3	31.2 ± 5.0	33.1 ± 3.8	37.6 ± 4.1d	40.6 ± 4.4d	39.6 ± 3.1d
CD8+	23.4 ± 4.1	15.0 ± 2.5	14.7 ± 2.8	20.9 ± 3.0f	22.0 ± 2.7f	21.4 ± 3.2f
β-EP	8.7 ± 2.3	3.2 ± 0.8	8.8 ± 2.1h	9.2 ± 1.8h	7.6 ± 2.0h	6.7 ± 1.6h

CD₃⁺: ^aP < 0.05,

^bP < vs Preoperation; CD₄⁺: ^cP < 0.05,

^dP < 0.01 vs Preoperation; CD₈⁺: ^eP < 0.05,

^fP < 0.01 vs Preoperation; β-EP: ^gP < 0.05,

^hP < 0.01 vs Preoperation.